|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2463-2469.
Prepublished online as a Blood First Edition Paper on June 6, 2006; DOI 10.1182/blood-2006-04-019059.
Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity
Bradley W. Blaser,
Noah R. Schwind,
Seth Karol,
Dennis Chang,
Samuel Shin,
Sameek Roychowdhury,
Brian Becknell,
Amy K. Ferketich,
Donna F. Kusewitt,
Bruce R. Blazar, and
Michael A. Caligiuri
From the Integrated Biomedical Sciences Graduate Program; the Department of Internal Medicine, Division of Hematology/Oncology; the Department of Molecular Virology, Immunology, and Medical Genetics; the Division of Epidemiology; the Department of Veterinary Biosciences; the Comprehensive Cancer Center at The Ohio State University, Columbus; the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis.
The "holy grail" of allogeneic stem cell transplantation is to preserve the graft-versus-tumor (GVT) effect while eliminating graft-versus-host disease (GVHD). Endogenous donor-derived interleukin 15 (IL-15) has been implicated in the pathogenesis of acute GVHD, yet the mechanism by which it impacts this lethal process remains unclear. Using the well-described and clinically relevant C57BL/6 B6D2F1 murine model of acute GVHD, we demonstrate that in trans presentation of IL-15 by donor bone marrowderived cells is required for the rapid onset of acute GVHD. Recipients of IL-15/ C57BL/6 bone marrow cells show diminished type 1 polarization of T cells, yet there is no decrease in donor T-cell reconstitution. A molecular basis for these findings is provided with the observation that expression of T-bet, the master control gene for type 1 T-cell functions, is necessary for IL-15mediated acute GVHD lethality. Finally, we demonstrate that in the absence of donor-derived IL-15, the GVT effect is maintained. These findings thus establish a mechanism by which endogenous donor-derived IL-15 impacts the pathobiology of acute GVHD and GVT activity.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Trans-presentation of IL-15
- Jerome Ritz
Blood 2006 108: 2135-2136.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
B. Morandi, L. Mortara, P. Carrega, C. Cantoni, G. Costa, R. S. Accolla, M. C. Mingari, S. Ferrini, L. Moretta, and G. Ferlazzo
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs
Int. Immunol.,
May 1, 2009;
21(5):
599 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Imanguli, W. D. Swaim, S. C. League, R. E. Gress, S. Z. Pavletic, and F. T. Hakim
Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa
Blood,
April 9, 2009;
113(15):
3620 - 3630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chakraverty and M. Sykes
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
Blood,
July 1, 2007;
110(1):
9 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|